Incidence of hematological toxicity with use of immunotherapy and chemotherapy in advanced non-small cell lung cancer

• Wenhai Fu,
• Yu Jiang,
• Wenjun Ye,
• Ran Zhong,
• Shan Xiong,
• Jianfu Li,
• Caichen Li,
• Jianxing He,
• Wenhua Liang,
• Xiangxiang Pan

Affiliations

Wenhai Fu

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Yu Jiang

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Wenjun Ye

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Ran Zhong

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Shan Xiong

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Jianfu Li

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Caichen Li

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Jianxing He

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Wenhua Liang

1 Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China

Xiangxiang Pan